Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Luspatercept”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04064060
What this trial is testing

Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Who this might be right for
Myelodysplastic Syndromes (MDS)Beta-thalassemiaMyeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene 665
Testing effectiveness (Phase 2)Looking for participantsNCT07725497
What this trial is testing

Luspatercept in People With Anemia

Who this might be right for
AnemiaChronic Kidney Disease
Memorial Sloan Kettering Cancer Center 30
Not applicableStudy completedNCT07075406
What this trial is testing

Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 250
Testing effectiveness (Phase 2)Looking for participantsNCT06517875
What this trial is testing

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
GlaxoSmithKline 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT06113302
What this trial is testing

A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
M.D. Anderson Cancer Center 10
Not applicableActive Not RecruitingNCT06913634
What this trial is testing

Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase

Who this might be right for
Thalassemia Major
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia 140
Not applicableActive Not RecruitingNCT06596642
What this trial is testing

A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

Who this might be right for
β-Thalassemia Major
Bristol-Myers Squibb 61
Post-approval studies (Phase 4)WithdrawnNCT06424639
What this trial is testing

Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06788691
What this trial is testing

Luspatercept for Clonal Cytopenias of Uncertain Significance

Who this might be right for
CCUS Clonal Cytopenia of Undetermined SignificanceAnemiaLeukopenia+2 more
Weill Medical College of Cornell University 50
Testing effectiveness (Phase 2)Study completedNCT03900715
What this trial is testing

An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

Who this might be right for
Myelodysplastic Syndromes
Celgene 21
Testing effectiveness (Phase 2)Temporarily pausedNCT04539236
What this trial is testing

Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Mikkael Sekeres, MD 50
Post-approval studies (Phase 4)UnknownNCT05462548
What this trial is testing

The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study

Who this might be right for
Thalassemia MajorTransfusion-dependent Anemia
Sun Yat-sen University 20
Large-scale testing (Phase 3)Study completedNCT02604433
What this trial is testing

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia

Who this might be right for
Erythrocyte TransfusionBeta-Thalassemia
Celgene 336
Not applicableStudy completedNCT06254781
What this trial is testing

Luspatercept in Metastatic AGCT of the Ovary

Who this might be right for
Adult Granulosa Cell Tumor of the Ovary
University Health Network, Toronto 1
Not applicableStudy completedNCT06851065
What this trial is testing

Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 418
Testing effectiveness (Phase 2)Looking for participantsNCT05181735
What this trial is testing

Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA

Who this might be right for
MDSMyelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 150
Testing effectiveness (Phase 2)Looking for participantsNCT05924100
What this trial is testing

Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD

Who this might be right for
Myelodysplastic SyndromesDel(5Q)Anemia+1 more
Associazione Qol-one 22
Testing effectiveness (Phase 2)Study completedNCT05399732
What this trial is testing

Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Bing Han 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05567458
What this trial is testing

Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

Who this might be right for
Beta-thalassemia
Bristol-Myers Squibb 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732961
What this trial is testing

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative NeoplasmAnemia
H. Lee Moffitt Cancer Center and Research Institute 6
Next Page